These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3040756)

  • 21. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol.
    Davidson WS; Gillotte KL; Lund-Katz S; Johnson WJ; Rothblat GH; Phillips MC
    J Biol Chem; 1995 Mar; 270(11):5882-90. PubMed ID: 7890719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of low and high density lipoprotein binding in vivo with rates of lipoprotein degradation in the rat. A comparison of lipoproteins of rat and human origin.
    Koelz HR; Sherrill BC; Turley SD; Dietschy JM
    J Biol Chem; 1982 Jul; 257(14):8061-72. PubMed ID: 6282871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efflux of phospholipid from fibroblasts with normal and elevated levels of cholesterol.
    Bielicki JK; Johnson WJ; Glick JM; Rothblat GH
    Biochim Biophys Acta; 1991 Aug; 1085(1):7-14. PubMed ID: 1892880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phospholipid transfer protein enhances removal of cellular cholesterol and phospholipids by high-density lipoprotein apolipoproteins.
    Wolfbauer G; Albers JJ; Oram JF
    Biochim Biophys Acta; 1999 Jul; 1439(1):65-76. PubMed ID: 10395966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of membrane lipid composition on the kinetics of cholesterol exchange between lipoproteins and different species of red blood cells.
    Gold JC; Phillips MC
    Biochim Biophys Acta; 1990 Aug; 1027(1):85-92. PubMed ID: 2397224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I.
    Oppenheimer MJ; Sundquist K; Bierman EL
    Diabetes; 1989 Jan; 38(1):117-22. PubMed ID: 2535824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of modified high density lipoproteins to endothelial cells: relation with cellular cholesterol efflux?
    Kilsdonk EP; van Gent T; Dorsman AN; van Tol A
    Atherosclerosis; 1992 Dec; 97(2-3):131-42. PubMed ID: 1466659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
    Marcil M; Yu L; Krimbou L; Boucher B; Oram JF; Cohn JS; Genest J
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):159-69. PubMed ID: 9888879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux.
    Duell PB; Oram JF; Bierman EL
    Diabetes; 1991 Mar; 40(3):377-84. PubMed ID: 1847886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
    Hall IH; Wong OT; Simlot R; Izydore RA
    Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a human hepatic receptor for high density lipoproteins.
    Hoeg JM; Demosky SJ; Edge SB; Gregg RE; Osborne JC; Brewer HB
    Arteriosclerosis; 1985; 5(3):228-37. PubMed ID: 2986587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation inactivation of binding sites for high density lipoproteins in human fibroblast membranes.
    Mendel CM; Kunitake ST; Kane JP; Kempner ES
    J Biol Chem; 1988 Jan; 263(3):1314-9. PubMed ID: 2826475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
    Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
    J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of phthalimide and saccharin derivatives on low-density lipoprotein (LDL) and high-density lipoprotein (HDL) receptor activity and related enzyme activities.
    Hall IH; Wong OT; Wyrick SD
    Pharm Res; 1988 Jul; 5(7):413-20. PubMed ID: 2854633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-regulation of high density lipoprotein receptor activity by gamma-interferon associated with inhibition of cell proliferation.
    Oppenheimer MJ; Oram JF; Bierman EL
    J Biol Chem; 1988 Dec; 263(36):19318-23. PubMed ID: 2848821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathway of cholesterol efflux from human hepatoma cells.
    Sviridov D; Fidge N
    Biochim Biophys Acta; 1995 May; 1256(2):210-20. PubMed ID: 7766700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of apolipoproteins AI, AII, and Cs on the metabolism of membrane and lysosomal cholesterol in macrophages.
    Mahlberg FH; Glick JM; Lund-Katz S; Rothblat GH
    J Biol Chem; 1991 Oct; 266(30):19930-7. PubMed ID: 1657906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of serum high density lipoproteins in adrenal steroidogenesis.
    Gwynne JT; Hess B; Hughes T; Rountree R; Mahaffee D
    Endocr Res; 1984-1985; 10(3-4):411-30. PubMed ID: 6100250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the cholesterol efflux induced by novel seminal phospholipid-binding proteins.
    Moreau R; Manjunath P
    Biochim Biophys Acta; 2000 Aug; 1487(1):24-32. PubMed ID: 10962285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.